Nektar Therapeutics · NASDAQ:NKTR
Nektar Therapeutics shareholders
As of Sep 30, 2026, 233 institutions reported holding Nektar Therapeutics. Largest: Fidelity, Two Seas Capital LP and BlackRock. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Nektar Therapeutics | Change | Filed |
|---|---|---|---|---|
| Fidelity | 5.12M | +53,521 | Nov 10, 2026 | |
| Two Seas Capital LP | 3.35M | +254K | Oct 6, 2026 | |
| BlackRock | 2.87M | −70,388 | Nov 13, 2026 | |
| Vanguard | 2.16M | +28,156 | Nov 16, 2026 | |
| Bvf Inc | 2.13M | −257K | Nov 16, 2026 | |
| State Street | 1.77M | +863K | Nov 12, 2026 | |
| Two Sigma | 1.21M | +6,266 | Nov 16, 2026 | |
| Geode Capital | 892K | +10,621 | Nov 6, 2026 | |
| Morgan Stanley | 830K | −106K | Nov 13, 2026 | |
| Prosight Management, LP | 785K | −25,000 | Nov 13, 2026 |